Showing results (511-520 of 597) with videos related to

Sort By:
Pageof 60
Critical Care Medicine|January 13, 2026
Identifying Research Priorities in Canadian Adult and Pediatric Critical Care: Results From a James Lind Alliance Priority Setting PartnershipKirsten M Fiest, Karla D Krewulak, Tamara Rader, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 20, 2019
A Next-Generation Single-Port Robotic Surgical System for Transoral Robotic Surgery: Results From Prospective Nonrandomized Clinical TrialsF Christopher Holsinger, J Scott Magnuson, Gregory S Weinstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitroPierpaolo Correale, Maria Grazia Cusi, Maria Teresa Del Vecchio, et al.
NPJ Genomic Medicine|September 23, 2020
A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysisJasmine L F Fung, Mullin H C Yu, Shushu Huang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinomaTan To Cheung, Sheung Tat Fan, Ferdinand S K Chu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 23, 2014
Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantationKenneth S H Chok, Tan To Cheung, Regina C L Lo, et al.
Nature Immunology|August 29, 2020
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.
Oncotarget|May 25, 2017
Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitorsGordon W Rewcastle, Sharada Kolekar, Christina M Buchanan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2023
Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guidelineR S Guninski, F Cuccia, F Alongi, et al.
Oncotarget|May 19, 2016
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cellsCaroline Jochems, Massimo Fantini, Romaine I Fernando, et al.
Pageof 60